468 related articles for article (PubMed ID: 21688623)
1. [Proton pump inhibitor H2 receptor antagonist].
Shiotani A; Kamada T; Kusunoki H; Manabe N; Haruma K
Nihon Rinsho; 2011 Jun; 69(6):1032-8. PubMed ID: 21688623
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
3. [Points that should be considered for selecting drugs for the prevention and treatment of NSAIDs-related ulcers].
Kinoshita Y; Tamagawa Y
Nihon Rinsho; 2011 Jun; 69(6):1044-8. PubMed ID: 21688625
[TBL] [Abstract][Full Text] [Related]
4. Primary prevention of ulcers in patients taking aspirin or NSAIDs.
Med Lett Drugs Ther; 2010 Mar; 52(1333):17-9. PubMed ID: 20300052
[TBL] [Abstract][Full Text] [Related]
5. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
6. Role of acid suppressants in prophylaxis of NSAID damage.
Chan FK; Sung JJ
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
[TBL] [Abstract][Full Text] [Related]
7. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
[TBL] [Abstract][Full Text] [Related]
8. [Prevention and treatment of nonsteroidal anti-inflammatory drugs induced ulcers].
Kobayakawa M; Uemura N
Nihon Rinsho; 2007 Oct; 65(10):1857-61. PubMed ID: 17926536
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
Dajani EZ; Agrawal NM
J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of NSAID induced gastroduodenal ulcers].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
[TBL] [Abstract][Full Text] [Related]
11. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
Rostom A; Wells G; Tugwell P; Welch V; Dubé C; McGowan J
J Rheumatol; 2000 Sep; 27(9):2203-14. PubMed ID: 10990235
[TBL] [Abstract][Full Text] [Related]
12. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
13. [NSAID ulcer (H. pylori, treatment, prevention)].
Ohta S; Arai S; Imai Y; Banba H
Nihon Rinsho; 2004 Mar; 62(3):505-11. PubMed ID: 15038095
[TBL] [Abstract][Full Text] [Related]
14. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
15. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
[TBL] [Abstract][Full Text] [Related]
16. [Treatment and prevention of histamine-2 receptor antagonist for elderly gastric ulcer].
Kamada T; Sato Y; Shiotani A; Haruma K
Nihon Rinsho; 2010 Nov; 68(11):2064-70. PubMed ID: 21061534
[TBL] [Abstract][Full Text] [Related]
17. Challenges in managing NSAID-associated gastrointestinal tract injury.
Goldstein JL
Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
[TBL] [Abstract][Full Text] [Related]
18. Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage.
Singh G; Triadafilopoulos G
Int J Clin Pract; 2005 Oct; 59(10):1210-7. PubMed ID: 16178990
[TBL] [Abstract][Full Text] [Related]
19. [Role of proton pump inhibitor in the management of low dose aspirin related ulcerations].
Hiraishi H; Shimada T
Nihon Rinsho; 2010 Nov; 68(11):2096-101. PubMed ID: 21061539
[TBL] [Abstract][Full Text] [Related]
20. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
Zhou JF; Wan XY; Huang W; Han LL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
